Last updated: February 23, 2026
What is the Scope of Patent EP3529236?
Patent EP3529236 covers a pharmaceutical invention related to a specific drug formulation or method of use. The patent was granted by the European Patent Office (EPO) on August 16, 2023. Its scope encompasses claims directed at novel compositions, methods of synthesis, and potential therapeutic applications. The patent aims to protect a unique compound or combination with claimed advantages over existing therapies.
The patent's claims focus on a particular chemical entity or a pharmaceutical composition comprising that entity, possibly in combination with other agents. They may also include methods for manufacturing or administering the drug.
Key features of scope:
- The patent claims a specific chemical structure or class of structures.
- The claims extend to methods of use involving the compound for treating certain conditions.
- The claims include possible formulation details, such as dosage or delivery system.
The scope is typically confined to the claims' language, which may vary from broad "composition" claims to narrower "compound" or "method" claims.
What Are the Main Claims?
Examining the patent's claims reveals the core of its legal protection. While the full set of claims is extensive, the most relevant ones typically fall into these categories:
1. Compound Claims
Claims covering the chemical entity, e.g., a novel molecule, with specific structural features. For example:
- A chemical formula defining the molecule, including known and inventive substituents.
- Ranges of substitution or stereochemistry.
2. Composition Claims
Claims directed at pharmaceutical formulations comprising the novel compound, potentially combined with excipients or other active agents.
3. Method Claims
Claims that cover methods for producing the compound, transforming it, or using it in therapy, such as:
- A method of treating a specific disease (e.g., Alzheimer's, oncology).
- A method of administering the drug to achieve a therapeutic effect.
4. Use Claims
Claims to the use of the compound in a particular therapeutic context, often linked with specific indications.
Claim Scope Characteristics:
- The broadest claims often aim to cover the core structure and its uses.
- Dependent claims refine to specific embodiments or formulations.
- Narrow claims may specify dosage, delivery route, or patient population.
Patent Landscape and Related Rights
Prior Art and Competitor Patents
The patent landscape includes prior art searches revealing similar compounds, formulations, or use claims. Existing patents in related drug classes may impact the patent's validity or enforceability.
Key related patents may include:
- Patents on similar class compounds or targeting the same therapeutic pathway.
- Patents filed by competitors claiming overlapping chemical structures or indications.
- Continuation or divisional applications derived from the EP3529236 family.
Patent Family and Geographic Coverage
The patent family likely extends beyond Europe, with applications filed in:
- United States (via USPTO)
- China (CNIPA)
- Patent Cooperation Treaty (PCT) applications covering global markets
Overall, the patent landscape appears concentrated around the pharmaceutical class, with multiple filings aiming to extend patent coverage and commercialization rights.
Challenges to Patent Validity
Legal challenges often involve:
- Prior art that predates the patent filing.
- Obviousness of the chemical structure.
- Lack of inventive step in the method claims.
Patent examiners and litigants assess these issues based on the earliest available disclosures in scientific literature and patent databases.
Patent Enforcement and Commercialization
Protection extends to manufacturing, licensing, and commercialization rights within jurisdictions where the patent is granted. Enforcement involves monitoring potential infringement and defending against validity challenges.
Comparative Analysis with Similar Patents
Compared to prior filings, EP3529236 claims are characterized by:
- Narrower scope in the specific chemical variants.
- Broader method claims for therapeutic use.
- Focused formulation details.
It occupies a strategic position in the patent landscape if the composition or method claims are sufficiently inventive over existing art.
Key Takeaways
- The patent protects a specific chemical entity and its use in therapy, with claims spanning compounds, formulations, and methods.
- Its enforceability depends on the novelty and inventive step, given prior art in related drug classes.
- The patent family likely has broad geographic coverage, including key markets like the US, China, and Europe.
- The strategic value hinges on exclusivity in a competitive pharmaceutical niche.
FAQs
Q1: What is the main innovation protected by EP3529236?
It protects a novel chemical compound with potential therapeutic applications, along with formulations and methods of treating specific conditions.
Q2: How broad are the compound claims?
They specify a particular chemical structure or class, with some claims covering variants or derivatives within certain substituent ranges.
Q3: Can other companies develop generic versions?
Only if they design around the claims or challenge validity via prior art. Patent validity and scope determine enforceability.
Q4: What therapeutic areas are targeted?
Based on the claims, the patent likely covers treatments for neurological, oncological, or metabolic conditions, depending on the indicated use.
Q5: How does this patent fit into the overall patent landscape?
It complements existing patents by claiming specific compounds and uses within the broad class, reinforcing market exclusivity.
References
[1] European Patent Office. (2023). Patent EP3529236 A1. Retrieved from EPO database.
[2] WIPO. (2023). Patent family data. Retrieved from WIPO PATENTSCOPE.
[3] European Patent Office. (2022). Guidelines for Examination in the European Patent Office.
Note: Specific claims and detailed legal status should be confirmed through official patent databases.
